Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to parkinson's disease

Neurourology and Urodynamics

Volumn 30, Issue 1, 2011, Pages 102-107

  Yamamoto, T ^a   Sakakibara, R ^a,c   Uchiyama, T ^a   Yamaguchi, C ^a   Nomura, F ^a   Ito, T ^a   Yanagisawa, M ^a   Yano, M ^a   Awa, Y ^a   Yamanishi, T ^b   Hattori, T ^a   Kuwabara, S ^a  

^a CHIBA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

multiple system atrophy; Parkinson's disease; parkinsonian syndrome; pelvic organ dysfunction

Indexed keywords

ADULT; AGED; ARTICLE; CONSTIPATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PARKINSON DISEASE; PELVIC ORGAN PROLAPSE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SHY DRAGER SYNDROME; URINARY URGENCY;

AGED; CONSTIPATION; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PELVIS; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; URINARY BLADDER DISEASES;

EID: 78651078157     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20948     Document Type: Article

References (15)

1. Wenning GK, Colosimo C, Geser F, et al. Multiple system atrophy. Lancet Neurol 2004; 3: 93-103.
2. Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001; 92: 76-85.
3. Ito T, Sakakibara R, Yasuda K, et al. Incomplete emptying and urinary retention in multiple-system atrophy: When does it occur and how do we manage it? Mov Disord 2006; 21: 816-23.
4. Wenning GK, Geser F, Stampfer-Kountchev M, et al. Multiple system atrophy: An update. Mov Disord 2003; S34-42.
5. Magerkurth C, Schnitzer R, Braune S,. Symptoms of autonomic failure in Parkinson's disease: Prevalence and impact on daily life. Clin Auton Res 2005; 15: 76-82.
6. Yamamoto T, Sakakibara R, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord 2009; 15: 972-8.
7. Zesiewicz TA, Sullivan KL, Gooch CL,. Red flags to spot the parkinsonian variant of multiple system atrophy. Nat Clin Pract Neurol 2008; 4: 596-7.
8. Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clinical features are most useful to distinguish definitive multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 68: 434-40.
9. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005; 26: 912-21.
10. Hirano S, Eckert T, Flanagan T, et al. Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Mov Disord 2009; 24: S725-31.
11. 123I- metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 189-94.
12. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Mov Disord 2009; 24: S732-41.
13. Sakakibara R, Hattori T, Uchiyama T, et al. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001; 71: 600-6.
14. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 26: 670-6.
15. Cersosimo MG, Benarroch EE,. Neural control of the gastrointestinal tract: Implications for Parkinson disease. Mov Disord 2008; 23: 1065-75.